The global healthcare cognitive computing market size was valued at USD 8.48 billion in 2023 and is projected to reach USD 44.65 billion by 2030, growing at a CAGR of 27.0% from 2024 to 2030. This rapid growth is primarily driven by the widespread adoption of cloud services, the increasing volume of patient data, and the rising prevalence of chronic diseases, including diabetes, cardiovascular conditions, and cancer.
The demand for big data and cognitive computing analysis in healthcare has surged, fueled by the growing amount of patient information and the need for advanced insights to improve diagnosis, treatment, and operational efficiency. Additionally, government initiatives and programs by leading medical institutes aimed at integrating advanced technologies into healthcare systems have significantly supported market expansion. The increase in disposable income and ongoing advancements in healthcare infrastructure further contribute to the adoption of cognitive computing solutions.
Cognitive computing technology is applied across multiple areas in medicine, including medical imaging analysis, personalized medicine, electronic health record (EHR) data analysis, and genomics research. The technology helps in studying gene defects and reduces the complexity associated with analyzing large-scale genetic and clinical data. These capabilities enhance diagnostic accuracy, treatment planning, and patient care, making cognitive computing a critical tool in modern healthcare.
Moreover, the rising prevalence of chronic diseases is a significant driver of market growth. There is a growing demand for gene-targeted therapies that specifically address cancer-causing cells while preserving healthy tissues. Healthcare providers are increasingly using third-party platforms and personalized care solutions to treat patients with conditions such as cancer and diabetes. The combination of technologically advanced treatment options and higher patient disposable income allows for wider adoption of personalized therapies, further propelling the growth of the healthcare cognitive computing market.
Key Market Trends Insights:
• In 2023, North America dominated the global healthcare cognitive computing market, capturing a revenue share of 38.8%. This dominance is driven by the region’s well-established healthcare infrastructure, high adoption of advanced technologies, and substantial investments in healthcare IT solutions. Within North America, the United States led the market, reflecting its strong focus on integrating cognitive computing solutions into healthcare systems, robust research and development activities, and early adoption of innovative healthcare technologies.
• When analyzed by technology, the natural language processing (NLP) segment dominated the market in 2023, accounting for a share of 41.9%. NLP technology is widely utilized in healthcare for analyzing unstructured clinical data, processing electronic health records (EHRs), and enhancing decision-making capabilities, thereby improving patient outcomes and operational efficiency.
• Regarding deployment models, the cloud segment dominated the market in 2023, with a share of 72.0%. Cloud-based deployment is preferred due to its scalability, cost-effectiveness, real-time accessibility, and ease of integration with existing healthcare systems. The adoption of cloud solutions enables healthcare providers to store and process large volumes of patient data securely, leverage advanced analytics, and deploy cognitive computing applications more efficiently across multiple facilities.
Order a free sample PDF of the Healthcare Cognitive Computing Market Intelligence Study, published by Grand View Research.
Market Size Forecast:
• 2023 Market Size: USD 8.48 Billion
• 2030 Projected Market Size: USD 44.65 Billion
• CAGR (2024-2030): 27.0%
• North America: Largest market in 2023
Key Companies Market Share Insights:
Some of the major companies operating in the global healthcare cognitive computing market include Microsoft, IBM Corporation, NVIDIA Corporation, Intel Corporation, Iterx Group, and several others. These companies are increasingly focusing on developing and deploying solutions that can be seamlessly integrated into medical procedures, with the aim of enhancing the accuracy of medical decisions, improving patient outcomes, and optimizing clinical workflows.
NVIDIA Corporation is a leading multinational technology company known for its design and development of graphics processing units (GPUs) and Application Programming Interfaces (APIs) used in data science, high-performance computing, and artificial intelligence. NVIDIA is also recognized as a major supplier of AI software and hardware, providing platforms that enable advanced cognitive computing applications in healthcare, such as predictive analytics, medical imaging analysis, and personalized treatment planning.
GE Healthcare is a prominent medical technology company that specializes in manufacturing and distributing diagnostic imaging agents and radiopharmaceuticals for various imaging modalities. In addition, the company produces a wide range of medical diagnostic equipment, including MRI systems, X-ray machines, ultrasound devices, and other imaging technologies. These solutions are instrumental in enhancing healthcare providers’ ability to collect, analyze, and interpret patient data, supporting more informed and accurate clinical decision-making.
Key Players
• Microsoft
• IBM Corporation
• NVIDIA Corporation
• Intel Corporation
• Iterx Group
• GE Healthcare
• Medtronic
• Oracle
• Medidata
Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.
Conclusion:
The healthcare cognitive computing market is experiencing significant growth, driven by the increasing adoption of cloud services and the rising prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. Technologies like natural language processing, machine learning, and automated reasoning are enhancing capabilities in medical imaging, personalized medicine, and electronic health record analysis. North America leads the market, with the U.S. at the forefront, owing to strong healthcare infrastructure and technological advancements. The market is also witnessing the development of solutions that integrate with medical procedures to improve decision-making accuracy.
